The long term aim of this project is to understand the molecular basis of cell-matrix adhesion, its effects on cell structure and behavior and the nature of alterations occurring in oncogenic transformation and related physiological/pathological systems.
The specific aims are to: 1. Use recombinant fibronectin (FN) constructs and proteins to investigate different cell interaction sites within FN, the receptors for them, and their roles in the behaviors of various cell types. 2. Analyze in detail the structure-function relationships of certain domains of FN using molecular genetic and biochemical approaches. 3. Particular attention will be paid to those segments of FN which are alternatively spliced and differentially expressed. 4. Investigate the control of alternative splicing of FN pre mRNA both in vivo and in vitro systems. 5. Study the functions and interactions with FN and with cytoplasmic proteins, including cytoskeletal proteins, of the various integrin subunits which make up FN receptors. These questions will be approached by molecular genetic and biochemical methods. 6. Investigate the interactions of the cytoskeletal protein talin with the cytoplasmic domains of integrins and with other cytoskeletal proteins. 7. Particular attention will be paid to the nature of alterations in integrin expression, function and interactions with FN and cytoplasmic proteins in oncogenically transformed cells. These studies should provide new insights into the molecular basis of cellular adhesion and its contribution to the structure and behavior of normal cells. The results will have relevance for understanding of embryological development, hemostasis, thrombosis, wound healing, inflammation, invasion and metastasis. All these processes involve cell adhesion to extracellular matrices and molecules identical or closely related to those under study in this project.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA017007-18
Application #
3164595
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1977-05-01
Project End
1995-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
18
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
Organized Research Units
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Roper, Jatin; Tammela, Tuomas; Cetinbas, Naniye Malli et al. (2017) In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat Biotechnol 35:569-576
Xie, Liang; Duncan, Michael B; Pahler, Jessica et al. (2011) Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner. Proc Natl Acad Sci U S A 108:9939-44
Hynes, Richard O (2009) The extracellular matrix: not just pretty fibrils. Science 326:1216-9
Xu, Lei; Shen, Steven S; Hoshida, Yujin et al. (2008) Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol Cancer Res 6:760-9
McCarty, Joseph H; Barry, Marc; Crowley, Denise et al. (2008) Genetic ablation of alphav integrins in epithelial cells of the eyelid skin and conjunctiva leads to squamous cell carcinoma. Am J Pathol 172:1740-7
Wong, Sunny Y; Crowley, Denise; Bronson, Roderick T et al. (2008) Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer. Clin Exp Metastasis 25:109-18
Wong, Sunny Y; Hynes, Richard O (2007) Tumor-lymphatic interactions in an activated stromal microenvironment. J Cell Biochem 101:840-50
Wong, Sunny Y; Haack, Herbert; Kissil, Joseph L et al. (2007) Protein 4.1B suppresses prostate cancer progression and metastasis. Proc Natl Acad Sci U S A 104:12784-9
Xu, Lei; Hynes, Richard O (2007) GPR56 and TG2: possible roles in suppression of tumor growth by the microenvironment. Cell Cycle 6:160-5
Wong, Sunny Y; Hynes, Richard O (2006) Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5:812-7

Showing the most recent 10 out of 68 publications